Development and accuracy of an artificial intelligence algorithm for acne grading from smartphone photographs

被引:53
作者
Seite, Sophie [1 ]
Khammari, Amir [2 ]
Benzaquen, Michael [3 ]
Moyal, Dominique [1 ]
Dreno, Brigitte [2 ]
机构
[1] La Roche Posay Dermatol Labs, 62 Quai Charles Pasqua, F-92300 Levallois Perret, France
[2] Nantes Univ Hosp, Dept Dermatol, Nantes, France
[3] Aix Marseille Univ, Hop Nord, AP HM, Dept Dermatol, Marseille, France
关键词
acne; algorithm; artificial intelligence; GEA scale; Global Acne Severity scale; Smartphone; lesion count; RELIABILITY; ADHERENCE;
D O I
10.1111/exd.14022
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We developed an artificial intelligence algorithm (AIA) for smartphones to determine the severity of facial acne using the GEA scale and to identify different types of acne lesion (comedonal, inflammatory) and postinflammatory hyperpigmentation (PIHP) or residual hyperpigmentation. Overall, 5972 images (face, right and left profiles) obtained with smartphones (IOS and/or Android) from 1072 acne patients were collected. Three trained dermatologists assessed the acne severity for each patient. One acne severity grade per patient (grade given by the majority of the three dermatologists from the two sets of three images) was used to train the algorithm. Acne lesion identification was performed from a subgroup of 348 images using a tagging tool; tagged images served to train the algorithm. The algorithm evolved and was adjusted for sensibility, specificity and correlation using new images. The correlation between the GEA grade and the quantification and qualification of acne lesions both by the AIA and the experts for each image were evaluated for all AIA versions. At final version 6, the GEA grading provided by AIA reached 68% and was similar to that provided by the dermatologists. Between version 4 and version 6, AIA improved precision results multiplied by 1.5 for inflammatory lesions, 2.5 for non-inflammatory lesions and by 2 for PIHP; recall was improved by 2.6, 1.6 and 2.7. The weighted average of precision and recall or F1 score was 84% for inflammatory lesions, 61% for non-inflammatory lesions and 72% for PIHP.
引用
收藏
页码:1252 / 1257
页数:6
相关论文
共 24 条
[1]  
Agnew Tamara, 2016, J Clin Aesthet Dermatol, V9, P40
[2]   Acne relapses: impact on quality of life and productivity [J].
Dreno, B. ;
Bordet, C. ;
Seite, S. ;
Taieb, C. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (05) :937-943
[3]   The influence of exposome on acne [J].
Dreno, B. ;
Bettoli, V. ;
Araviiskaia, E. ;
Sanchez Viera, M. ;
Bouloc, A. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (05) :812-819
[4]   Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe [J].
Dreno, B. ;
Poli, F. ;
Pawin, H. ;
Beylot, C. ;
Faure, M. ;
Chivot, M. ;
Auffret, N. ;
Moyse, D. ;
Ballanger, F. ;
Revuz, J. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (01) :43-48
[5]   Recent data on epidemiology of acne [J].
Dreno, B. .
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2010, 137 :S49-S51
[6]   Large-scale worldwide observational study of adherence with acne therapy [J].
Dreno, Brigitte ;
Thiboutot, Diane ;
Gollnick, Harald ;
Finlay, Andrew Y. ;
Layton, Alison ;
Leyden, James J. ;
Leutenegger, Eric ;
Perez, Montserrat .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (04) :448-456
[7]  
FDA, 2018, ACN VULG EST EFF DRU
[8]  
Gold LS, 2016, J DRUGS DERMATOL, V15, P79
[9]  
Jamil A, 2016, MALAYS J MED SCI, V23, P78
[10]   Scarred for life? [J].
Layton, AM ;
Seukeran, D ;
Cunliffe, WJ .
DERMATOLOGY, 1997, 195 :15-21